Application of mPEG-CS-cRGD/<i>Bmi-1RNAi</i>-PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells.

Drug Deliv · 2023 · PMC9946312 · PMID 38095348

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In vitro, Cells enriched with PTX of C-myc, Nanog, Oct-4 and Sox-2 in laryngeal Hep-2 cells, all showed a decreasing trend ( Figure 3f ∼ g ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.